ROYSTON GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: C85005 | BARNSLEY, S71 4QW
Showing results 101-150 of 536
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 369 | 178.9K | £1.1K | +304.7% ▲ | |
| Hydrocortisone | 356 | 9,650 | £2.0K | -20.6% ▼ |
| Venlafaxine | 351 | 15.3K | £1.8K | -58.5% ▼ |
| Finasteride | 347 | 13.2K | £466 | -47.0% ▼ |
| Trazodone hydrochloride | 329 | 30.4K | £1.6K | +61.0% ▲ |
| Biphasic insulin aspart | 323 | 2,406 | £14.3K | +218.1% ▲ |
| Desogestrel | 319 | 63.0K | £1.9K | -19.5% ▼ |
| Beclometasone dipropionate | 317 | 323 | £939 | +47.4% ▲ |
| Donepezil hydrochloride | 311 | 8,515 | £571 | +0.8% vs avg |
| Quinine sulfate | 311 | 8,001 | £1.2K | +7.4% ▲ |
| Buprenorphine | 309 | 1,339 | £5.3K | -15.6% ▼ |
| Hyoscine butylbromide | 307 | 21.3K | £1.6K | +31.7% ▲ |
| Timolol and bimatoprost | 302 | 4,743 | £5.3K | +99.0% ▲ |
| Docusate sodium | 296 | 25.9K | £2.1K | -20.2% ▼ |
| Dorzolamide | 295 | 5,635 | £2.7K | +255.0% ▲ |
| Ticagrelor | 292 | 16.7K | £16.3K | +243.4% ▲ |
| Fluticasone/umeclidinium/vilanterol | 291 | 330 | £14.0K | +24.1% ▲ |
| Lercanidipine hydrochloride | 289 | 13.4K | £1.4K | -53.2% ▼ |
| Aripiprazole | 283 | 5,999 | £896 | +11.2% ▲ |
| Estradiol | 281 | 22.3K | £3.7K | -65.8% ▼ |
| 279 | 487 | £462 | +26.6% ▲ | |
| Sumatriptan succinate | 274 | 2,915 | £416 | -22.6% ▼ |
| Letrozole | 273 | 10.1K | £920 | +46.2% ▲ |
| Fludrocortisone acetate | 272 | 9,159 | £1.4K | +157.8% ▲ |
| Carbomer 940/980 | 271 | 4,460 | £743 | +78.0% ▲ |
| 269 | 290 | £1.6K | +13.9% ▲ | |
| 260 | 271 | £12.0K | -16.3% ▼ | |
| Mometasone furoate | 260 | 288 | £2.2K | -35.2% ▼ |
| Felodipine | 257 | 11.2K | £1.0K | -56.7% ▼ |
| Diazepam | 254 | 9,493 | £194 | -49.0% ▼ |
| Ferrous sulfate | 253 | 8,243 | £292 | -50.8% ▼ |
| Medroxyprogesterone acetate | 249 | 249 | £1.4K | +106.2% ▲ |
| Ivabradine | 247 | 10.4K | £996 | +159.8% ▲ |
| Mirabegron | 245 | 7,490 | £6.9K | -39.0% ▼ |
| Esomeprazole | 239 | 11.8K | £1.1K | -40.9% ▼ |
| Diltiazem hydrochloride | 235 | 12.3K | £1.6K | -23.5% ▼ |
| Oxycodone hydrochloride | 235 | 17.5K | £2.5K | -8.2% ▼ |
| Zopiclone | 234 | 4,040 | £175 | -57.7% ▼ |
| Pravastatin sodium | 230 | 10.9K | £480 | -29.2% ▼ |
| Eplerenone | 228 | 6,706 | £846 | -14.0% ▼ |
| Methotrexate | 226 | 5,818 | £1.4K | -30.6% ▼ |
| Sacubitril/valsartan | 222 | 12.2K | £20.0K | -7.3% ▼ |
| Pramipexole | 222 | 7,836 | £1.3K | +126.1% ▲ |
| Perindopril erbumine | 221 | 9,217 | £708 | -58.4% ▼ |
| Loratadine | 220 | 9,910 | £240 | +5.3% ▲ |
| Rivaroxaban | 218 | 7,089 | £4.8K | -64.4% ▼ |
| Estradiol with progestogen | 218 | 8,085 | £8.9K | -36.0% ▼ |
| Tirzepatide | 217 | 223 | £21.1K | +11.7% ▲ |
| Theophylline | 216 | 9,380 | £4.8K | +158.3% ▲ |
| Mesalazine (Systemic) | 208 | 25.5K | £9.6K | -13.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.